Crypineo

Crypineo is a combined oral contraceptive tablet containing the synthetic hormones drospirenone and ethinylestradiol. Marketed in the European Union, the product is prescribed for the prevention of pregnancy and for regulation of menstrual cycles. The formulation delivers a fixed dose of each active ingredient in a single tablet taken by mouth. Crypineo belongs to the hormonal contraceptive class and works by suppressing ovulation and altering cervical mucus.

Crypineo is indicated for several reproductive health purposes in women of child‑bearing age, providing reliable contraception and cycle management.

- Prevention of pregnancy when taken as directed in a 21‑day active tablet regimen. - Regulation of irregular menstrual bleeding and reduction of dysmenorrhea. - Management of acne associated with hormonal fluctuations. - Decrease in the risk of ovarian cyst formation. - Potential benefit in reducing premenstrual syndrome symptoms.

Like other combined oral contraceptives, Crypineo may cause side effects that vary in frequency and severity. Most side effects are mild and often resolve within the first few cycles of use.

Common: - Nausea, vomiting, or mild gastrointestinal upset. - Breast tenderness or enlargement. - Headache or mild migraine. - Spotting or breakthrough bleeding between periods. - Mood changes or mild depression. - Weight gain or fluid retention.

Serious: - Deep vein thrombosis or pulmonary embolism. - Severe hypertension or hypertensive crisis. - Liver dysfunction indicated by jaundice or abnormal liver enzymes.

Before prescribing Crypineo, clinicians assess individual risk factors and medical history to ensure safe use.

- History of thromboembolic disorders, stroke, or myocardial infarction. - Uncontrolled hypertension or cardiovascular disease. - Smoking in women over 35 years of age. - Liver disease, including hepatitis or cirrhosis. - Known or suspected pregnancy. - Breast cancer or estrogen‑dependent tumors. - Migraine with aura. - Severe diabetes with vascular complications.

Crypineo can interact with other medications, affecting its efficacy or increasing health risks.

Avoid: - Strong enzyme inducers such as rifampin, carbamazepine, phenytoin, and St John’s wort. - Certain antiretrovirals (e.g., protease inhibitors) that reduce contraceptive effectiveness. - Certain anticonvulsants (e.g., phenobarbital) that lower hormone concentrations.

Use with caution: - Antifungal agents like ketoconazole that may increase hormone levels. - Antidepressants (SSRIs) that can affect bleeding patterns. - Diuretics that may increase risk of hypertension. - Herbal supplements that influence estrogen metabolism. - Selective serotonin reuptake inhibitors that may increase risk of mood changes. - Herbal products containing phytoestrogens (e.g., soy isoflavones).